1.
Open Forum Infect Dis
; 9(7): ofac238, 2022 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35854994
RESUMO
Nirmatrelvir/ritonavir was recently granted emergency use authorization for mild to moderate coronavirus disease 2019. Drug-drug interactions between ritonavir and tacrolimus are underappreciated by nontransplant providers. We describe 2 solid organ transplant recipients prescribed nirmatrelvir/ritonavir for outpatient use who developed tacrolimus toxicity requiring hospitalization and were managed with rifampin for toxicity reversal.